|
Joachim Trier
|
Online Medical Education Improves Physicians’
Understanding of the Health Benefits of Sustained
Weight Loss and Competence in the Practical
Management of Persons Living With Obesity.
Supported by Novo Nordisk
|
|
|
Joachim Trier
|
Online Medical Education Advances Physicians’ Understanding of the Clinical Benefits
of Sodium-Glucose Cotransporter 2 Inhibition in Chronic Kidney Disease Management
Supported by Boehringer Ingelheim & Eli Lilly Alliance
|
|
|
Joachim Trier
|
Case-Based Online Medical Education improves Physicians’ Knowledge and
Competence in the Healthcare of Patients With Type 2 Diabetes and CKD.
Supported by Bayer AG; ERA
|
|
|
Siggi Trier
|
ESOPRS 2025
Online Medical Education Can Significantly Improve Knowledge on Pathophysiology, Diagnosis, and Management of Thyroid Eye Disease and Increase Confidence in Guideline Interpretation
Supported by Amgen
|
|
|
Siggi Trier
|
Euretina 2025
Online Medical Education Can Significantly Improve Ophthalmologists' Knowledge and Confidence When Using Longer-Acting Therapies in Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
Supported by Roche
|
|
|
Siggi Trier
|
ESPE/ESE 2025
Thyroid Eye Disease: Online Medical Education Unveils Knowledge Gaps and Barriers Regarding Targeted Immunotherapy
Supported by Amgen
|
|
|
Siggi Trier
|
Euretina 2024
Online Medical Education Can Significantly Improve Ophthalmologists’ Knowledge and Confidence to Use Imaging to Screen and Monitor Patients With Advanced Age-Related Macular Degeneration (AMD)
Supported by Apellis
|
|
|
Siggi Trier
|
Leber Hereditary Optic Neuropathy (LHON): Online Medical Education Can Significantly Improve Physicians’ Diagnostic Competence and Confidence, and Improve Therapy Knowledge.
Supported by Gensight Biologics
|
|
|
Siggi Trier
|
Ocular Surface Pain: Online Medical Education Can Significantly Improve Ophthalmologists’ Knowledge on Causative Factors, Diagnostic Methods, and Emerging Therapies and Increase Confidence for Patient Assessment.
Supported by Novartis
|
|
|
Siggi Trier
|
Can Participation in Virtual Patient Simulation Improve Glaucoma Diagnosis and Management?
Supported by Alcon/Novartis
|
|
